Publications by authors named "Colin R James"

Claim this Profile
A
Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer.
Eileen E Parkes, Kienan I Savage, Tong Lioe, Clinton Boyd, Sophia Halliday, Jaqueline A James, Colin R James

Br J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer.
Jude M Mulligan, Laura A Hill, Steve Deharo, Gareth Irwin, David Boyle, Colin R James, Jacqueline James

J Natl Cancer Inst· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcome.
Jonathan Krell, Colin R James, Deep Shah, Ondrej Gojis, Adrian Lim

Clin Breast Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rechallenging with anthracyclines and taxanes in metastatic breast cancer.
Carlo Palmieri, Jonathan Krell, Colin R James, Catherine Harper-Wynne, Vivek Misra

Nat Rev Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer.
Julia J Gorski, Colin R James, Jennifer E Quinn, Gail E Stewart, Kieran Crosbie Staunton

Breast Cancer Res Treat· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 and implications for response to chemotherapy in ovarian cancer.
Jennifer E Quinn, Judith E Carser, Colin R James, Richard D Kennedy, D Paul Harkin

Gynecol Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy.
Jennifer E Quinn, Colin R James, Gail E Stewart, Jude M Mulligan, Patricia White

Clin Cancer Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.
Alison M Hosey, Julia J Gorski, Margaret M Murray, Jennifer E Quinn, Wen Y Chung, Colin R James

J Natl Cancer Inst· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1, a potential predictive biomarker in the treatment of breast cancer.
Colin R James, Jennifer E Quinn, Paul B Mullan, Patrick G Johnston, D Paul Harkin

Oncologist· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.
Richard D Kennedy, Julia J Gorski, Jennifer E Quinn, Gail E Stewart, Colin R James

Cancer Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis